Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Xolair Enhances Oral Desensitization in Peanut Allergic Patients

NCT01290913 is registered in ClinicalTrials.gov with Lynda Schneider as lead sponsor.

NCT NCT01290913
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01290913 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Xolair Enhances Oral Desensitization in Peanut Allergic Patients
Lead sponsor
Lynda Schneider
Phase
Phase 1/2
Overall status
Completed
Start date
February 28, 2011
Completion date
September 30, 2013
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peanut allergy